Mifepristone has been FDA-approved for over 20 years—until anti-abortion activists handpicked right-wing Texas judge Matthew Kacsmaryk to take this case.
Evan Masingill, CEO of generic mifepristone manufacturer GenBioPro, said the company is reviewing the ruling, but “the bottom line is, we are confident in the legality of mifepristone’s approval.”, but slightly less effective than medication abortions done with both drugs. Jamila Perritt, an OB/GYN and the president and CEO of Physicians for Reproductive Health, told reporters on a recent press call that none of the legal issues around the abortion pill have to do with its safety.
“It would be one thing if they were saying ‘oh, we need to ban this medicine because it’s not safe, all these terrible things are happening.’ That’s not what’s happening.”, said on a press call she expected patients to be very confused as people called the clinic beforefell unsure if they could get a legal abortion.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
A Trump-Appointed Judge Has Halted the FDA Approval Of a Leading Abortion PillJudge Matthew Kacsmaryk has stayed the FDA’s approval of a medication used in nearly half of abortions carried out nationwide, in what could be the most far-reaching limit on abortion since the end of Roe. The federal government has seven days to respond.
続きを読む »
Federal judge halts FDA approval of abortion pill mifepristoneU.S. District Judge Matthew Kacsmaryk was appointed by former President Donald Trump.
続きを読む »
Did Daughter of Judge in Trump Hush-Money Case Work for Harris, Biden Campaigns?✅ True. The daughter of the judge assigned to Trump's case was the director of digital persuasion for Kamala Harris' 2020 presidential campaign. She also worked, indirectly, for the Biden-Harris 2020 campaign through a communications firm.
続きを読む »
Fox host speaks out against Trump criticizing judge's family'Fox & Friends' co-host Steve Doocy said talking about Judge Juan Merchan's family was a 'bad look' for former President Donald Trump.
続きを読む »